Cargando…

Ruxolitinib: Rebound effect manifested as acute hypoxaemic respiratory failure: 3 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661358/ http://dx.doi.org/10.1007/s40278-021-07225-8

Ejemplares similares

Hydroxychloroquine/tacrolimus: Peripheral T-cell lymphoma unspecified and acute hypoxaemic respiratory failure: case report
Publicado: (2017)

Awake prone positioning in acute hypoxaemic respiratory failure
por: McNicholas, Bairbre A., et al.
Publicado: (2023)

Dexamethasone: Worsening of respiratory failure following rebound effect: case report
Publicado: (2022)

The pandemic and the great awakening in the management of acute hypoxaemic respiratory failure
por: Shekar, Kiran, et al.
Publicado: (2022)

Ruxolitinib: Viral respiratory infections: case report
Publicado: (2019)

Prevalence and Outcomes of Acute Hypoxaemic Respiratory Failure in Wales: The PANDORA-WALES Study
por: Kopczynska, Maja, et al.
Publicado: (2020)

Outcome predictors of non-invasive positive pressure ventilation in hypoxaemic acute respiratory failure
por: Jog, S, et al.
Publicado: (2006)

Comparison of two non-bronchoscopic methods for evaluating inflammation in patients with acute hypoxaemic respiratory failure
por: Colucci, Giuseppe, et al.
Publicado: (2009)

Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure
por: Li, Qinyuan, et al.
Publicado: (2022)

Non-invasive ventilation for acute hypoxaemic respiratory failure: a propensity-matched cohort study
por: Jayasimhan, Dilip, et al.
Publicado: (2022)

Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives
por: Touchon, François, et al.
Publicado: (2021)

Outcomes in mechanically ventilated patients with hypoxaemic respiratory failure caused by COVID-19
por: Camporota, Luigi, et al.
Publicado: (2020)

Pulmonary embolism: yet another cause of hypoxaemic respiratory failure in COVID-19
por: Nieri, Dario, et al.
Publicado: (2020)

Ruxolitinib: Thrombocytopenia following compassionate use of ruxolitinib: 2 case reports
Publicado: (2022)

A negative trial for vasoactive intestinal peptide in COVID-19-associated acute hypoxaemic respiratory failure
por: Lee, Warren L, et al.
Publicado: (2023)

Ipilimumab/nivolumab/prednisolone: Nephritis and rebound renal failure: case report
Publicado: (2021)

Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
por: Booker, James, et al.
Publicado: (2022)

Ibrutinib: Rebound effect in the form of respiratory deterioration following the discontinuation of ibrutinib: case report
Publicado: (2021)

AZD-1222/prednisone: Chronic spontaneous urticaria and rebound effect manifested as pruritic rash and angioedema : case report
Publicado: (2022)

What is the most adequate non-invasive oxygen support for acute hypoxaemic respiratory failure due to COVID-19?
por: Frat, Jean-Pierre, et al.
Publicado: (2021)

Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre
por: Sivaloganathan, Arjjana A., et al.
Publicado: (2020)

Rethinking the efficacy of awake prone positioning in COVID-19-related acute hypoxaemic respiratory failure – Authors' reply
por: Luo, Jian, et al.
Publicado: (2022)

Ruxolitinib: Extreme thrombocytosis: case report
Publicado: (2021)

Methylprednisolone: Rebound pneumonia: case report
Publicado: (2022)

ABO blood types and major outcomes in patients with acute hypoxaemic respiratory failure: A multicenter retrospective cohort study
por: Rezoagli, Emanuele, et al.
Publicado: (2018)

Acute hypoxaemic respiratory failure in a low-income country: a prospective observational study of hospital prevalence and mortality
por: Kwizera, Arthur, et al.
Publicado: (2020)

Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib
por: Kerget, Bugra, et al.
Publicado: (2017)

Acute respiratory failure as a manifestation of an arachnoid cyst
por: Pillai, Lalitha V., et al.
Publicado: (2008)

Acute respiratory failure as a first manifestation of syringomyelia
por: Al Bashapshe, Ali, et al.
Publicado: (2010)

Acute Respiratory Failure as the First Manifestation of Antisynthetase Syndrome
por: Toujani, Sonia, et al.
Publicado: (2017)

Multiple drugs: DRESS-syndrome and rebound effect: case report
Publicado: (2022)

Acute respiratory failure as initial manifestation of conventional osteosarcoma rich in giant cells: a case report
por: Mosquera-Salas, Laura, et al.
Publicado: (2020)

Iloprost: Diarrhoea, rebound tachycardia and worsening of symptoms: 3 case reports
Publicado: (2020)

Prone positioning for non-intubated spontaneously breathing patients with acute hypoxaemic respiratory failure: a systematic review and meta-analysis
por: Fazzini, Brigitta, et al.
Publicado: (2022)

Unexpected Neurological Symptoms of Ruxolitinib: A Case Report
por: Furia, Francesca, et al.
Publicado: (2020)

Hypoxaemic burden in heart failure patients receiving adaptive servo‐ventilation
por: Baumert, Mathias, et al.
Publicado: (2023)

Fingolimod: Rebound effect in the form of exacerbation of COVID-19: case report
Publicado: (2021)

Mepolizumab/omalizumab/triamcinolone: Lack of efficacy and rebound effect: case report
Publicado: (2022)

Efficacy of non-invasive and invasive respiratory management strategies in adult patients with acute hypoxaemic respiratory failure: a systematic review and network meta-analysis
por: Sakuraya, Masaaki, et al.
Publicado: (2021)

Dexamethasone: Rebound of COVID-19-pneumonia: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ooofrbn071ts6j8druki15rgmq